Combination of Cisplatin and 5-Fluorouracil in the Treatment of Advanced Breast Cancer
Chapter
Abstract
Combination of Cisplatin (CDDP) and 5-Fluorouracil (5-FU) has been shown to have an encouraging activity both in rodent tumor systems (1), and in the treatment of various solid tumors (2), particularly in head and neck carcinoma, testicular and ovarian cancer, and more recently, in bladder carcinoma.
Keywords
Breast Cancer Ovarian Cancer Metastatic Breast Cancer Testicular Cancer Bladder Carcinoma
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- 1 -.Schabel F.M.,Jr., Trader M.W., Laster W.R.,Jr. Cancer Treat. Rep. 63: 1459–1473, 1979.PubMedGoogle Scholar
- 2 -.Prestayko A.W., D’Aoust J.C.D., Issel B.F., Crooke S.T. Cancer Treat. Rev. 6: 17–39, 1979.PubMedCrossRefGoogle Scholar
- 3 -.Kolaric K., Roth A. Cancer Chemother. Pharmacol. 11: 108–112, 1983.PubMedCrossRefGoogle Scholar
- 4 -.Kolaric K., Vukas D., Roth A., Potrebica V., Cervek J., Cerar O. Proc. Am. Soc. Clin. Oncol. 4: 66, 1985 (Abstract n.C-256).Google Scholar
- 5 -.Jacobs S.A., Stoller R.G., Earle M.F., Brunetti M. Proc. Am. Soc. Clin. Oncol. 4: 71, 1985 (Abstract n.C-274).Google Scholar
Copyright information
© Martinus Nijhoff Publishing, Boston 1988